Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + platinum-doublet chemotherapy
nivolumab plus platinum-doublet chemotherapy · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with resectable NSCLC and tumors at least 4 cm or with nodal involvement, receiving nivolumab plus a platinum doublet before surgery.
LAMPGEN ANALYSIS
Why it matters
This moves checkpoint blockade into the preoperative treatment window for selected resectable disease.
What research teams should watch
Track staging, therapy dates and the surgical handoff so treatment does not obscure operability or planned resection.
PRIMARY RECORDS